Ginger is currently one of the most popular herbs commonly
added
to diverse foods, beverages, and dietary supplements. We evaluated
the ability of a well-characterized ginger extract, and several of
its phytoconstituents, to activate select nuclear receptors as well
as modulate the activity of various cytochrome P450s and ATP-binding
cassette (ABC) transporters because phytochemical-mediated modulation
of these proteins underlies many clinically relevant herb–drug
interactions (HDI). Our results revealed ginger extract activated
the aryl hydrocarbon receptor (AhR) in AhR-reporter cells and pregnane
X receptor (PXR) in intestinal and hepatic cells. Among the phytochemicals
investigated, (S)-6-gingerol, dehydro-6-gingerdione,
and (6S,8S)-6-gingerdiol activated
AhR, while 6-shogaol, 6-paradol, and dehydro-6-gingerdione activated
PXR. Enzyme assays showed that ginger extract and its phytochemicals
dramatically inhibited the catalytic activity of CYP3A4, 2C9, 1A2,
and 2B6, and efflux transport capabilities of P-glycoprotein (P-gp)
and breast cancer resistance protein (BCRP). Dissolution studies with
ginger extract conducted in biorelevant simulated intestinal fluid
yielded (S)-6-gingerol and 6-shogaol concentrations
that could conceivably exceed cytochrome P450 (CYP) IC50 values when consumed in recommended doses. In summary, overconsumption
of ginger may disturb the normal homeostasis of CYPs and ABC transporters,
which in turn, may elevate the risk for HDIs when consumed concomitantly
with conventional medications.